Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Zinc finger protein 616 (ZNF616)** is a member of the large zinc finger protein family, which typically acts as DNA-binding transcription factors regulating gene expression. ZNF616 is predicted to participate in regulation of transcription by RNA polymerase II and is thought to be localized in the nucleus[5]. While zinc finger protein family members are implicated in diverse cellular processes such as cell differentiation, apoptosis, immune response, and cancer progression, there is limited specific literature directly linking ZNF616 to concrete biological pathways, disease roles, or drug interactions[1][3][5]. The gene encoding ZNF616 is listed as protein coding, primarily annotated as a potential transcription regulator[5][4]. If more targeted information regarding drugs, biomarkers, or disease involvement emerges in the future, those entries can be filled accordingly. **Note:** - ZNF616 should not be confused with similarly named zinc finger proteins such as ZNF16[2]. - Current evidence does not support its use as a therapeutic target, biomarker, or drug interaction partner based on available curated databases and gene summaries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 616 (ZNF616).